COMMUNIQUÉS West-GlobeNewswire

Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
18/12/2025
Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted DSR patents in US, Europe, Japan and China Strengthens DSR patent protection based upon extensive clinical and pre-clinical experience Data [...]
GlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD)
18/12/2025
PRESS RELEASE — FOR IMMEDIATE RELEASE GlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD) MHD technology draws micro-sample through skin; glucose is measured [...]
DXS International plc (AQSE:DXSP) Notice of Cyber Security Incident
18/12/2025
18 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of Cyber Security Incident The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital [...]
EssilorLuxottica et Burberry renouvellent leur accord de licence
18/12/2025
EssilorLuxottica et Burberry renouvellent leur accord de licence Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de [...]
EssilorLuxottica and Burberry announce licensing partnership renewal
18/12/2025
EssilorLuxottica and Burberry announce licensing partnership renewal Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement [...]
FoRx Therapeutics Announces USD 50M Series A Financing, Enabling Clinical Data Readout for Potential Best-in-Class PARG Inhibitor
18/12/2025
Funding to support Phase 1 clinical development of best-in-class PARG inhibitor candidate FORX-428 FORX-428 is potential new treatment option for patients whose cancers are resistant to, or have become resistant to, [...]
InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
18/12/2025
BEIJING, Dec. 17, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the [...]
New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success
17/12/2025
Produced by KreaMedica, in partnership with Venture Valuation and Lacerta Bio: three leading advisors to early-stage biotechs MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Three of the biotech industry’s trusted advisory [...]
Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare
17/12/2025
Daix (France), New York City (New York, États-Unis ), le 17 décembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
Daix (France), New York City (New York, United States), December 17, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
17/12/2025
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Breadth of Scientific Evidence: The [...]
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
17/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
17/12/2025
– End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA – – Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 – – Overall survival [...]
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
17/12/2025
In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells Lehi, Utah, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, December 17, [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
17/12/2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 17 déc. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Voting Rights and Shares Capital of the Company
17/12/2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Dec. 17, 2025 (GLOBE NEWSWIRE [...]
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
17/12/2025
HONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e- [...]
Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
ATLANTA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 44 th Annual J.P. Morgan Healthcare Conference in San [...]
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
17/12/2025
San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sapu BioScience today announced the publication of a new peer-reviewed study in the International Journal of Molecular Sciences that strengthens the scientific foundation [...]

Pages